Research & Development

任你干在线精品视频/这里总有您喜欢的任你干在线精品视频/这里总有您喜欢的北京公布家具抽检结果 无印良品与宜家等公司上黑榜


  他以為,只有他一個人想過回來。   “嗯。”任你干   黎舟沒懂,“什麼?”在线精品视频/这里总有您喜欢的任你干   葉紅玉又問他,“你黎媽媽真的答應了嗎?”   陸老大喝醉了力氣大,簡直人如其名像是一頭老虎,葉紅玉把人安撫住之後,又喊了兩個徒弟進來把陸老大送回房間去。在线精品视频/这里总有您喜欢的   “開家長會的時候,老師點名就會問呀。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo